Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 19.32% vs 43.98% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -34.87% vs 3,100.00% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -40.29% vs 407.35% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Taiko Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 19.32% vs 43.98% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 26.56% vs 0.59% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -34.87% vs 3,100.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 38.04% vs 106.03% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is -40.29% vs 407.35% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 764.52% vs 91.95% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -50.00% vs 0.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






